Induction of Drug Metabolism: The Role of Nuclear Receptors

Pharmacological Reviews

Volumn 55, Issue 4, 2003, Pages 649-673

  Handschin, Christoph ^a,b   Meyer, Urs A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALCOHOL; ANDROSTANE RECEPTOR; BISPHOSPHONIC ACID DERIVATIVE; CELL NUCLEUS RECEPTOR; CLOFIBRATE; CYTOCHROME P450; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 3A; DEXAMETHASONE; ISONIAZID; PHENOBARBITAL; POLYCYCLIC AROMATIC HYDROCARBON; PREGNANE X RECEPTOR; RETINOID X RECEPTOR; RIFAMPICIN; STEROID RECEPTOR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

BACILLUS MEGATERIUM; DNA BINDING; DRUG CONJUGATION; DRUG METABOLISM; DRUG OXIDATION; DRUG TARGETING; ENZYME INDUCTION; ENZYME KINETICS; GENETIC VARIABILITY; HUMAN; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SENSOR; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; GENE TARGETING; HUMANS; KINETICS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 0344740559     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.55.4.2     Document Type: Review

References (297)

1. Adesnik M, Bar-Nun S, Maschio F, Zunich M, Lippmän A, and Bard E (1981) Mechanism of induction of cytochrome P-450 by phenobarbital. J Biol Chem 256:10346-10353.
2. Akiyama TE and Gonzalez FJ (2003) Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochim Biophys Acta 1619:223-234.
3. Althaus FR, Sinclair JF, Sinclair P, and Meyer UA (1979) Drug-mediated induction of cytochrome(s) P-450 and drug metabolism in cultured hepatocytes maintained in chemically defined medium. J Biol Chem 254:2148-2153.
4. Andersin T, Väisänen S, and Carlberg C (2003) The critical role of carboxy-terminal amino acids in ligand-dependent and -independent transactivation of the constitutive androstane receptor. Mol Endocrinol 17:234-246.
5. Auerbach SS, Ramsden R, Stoner MA, Verlinde C, Hassett C, and Omiecinski CJ (2003) Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res 31:3194-3207.
6. Baader M, Gnerre C, Stegeman JJ, and Meyer UA (2002) Transcriptional activation of cytochrome P450 CYP2C45 by drugs is mediated by the chicken xenobiotic receptor (CXR) interacting with a phenobarbital response enhancer unit. J Biol Chem 277:15647-15653.
7. Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, and Moore DD (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14:1544-1552.
8. Baffet G and Corcos L (1995) The liver-specific response to phenobarbital involves a transient increase in phosphorylation of a 34-kda nuclear protein in rat liver and in hepatocytes in culture. Biochem Biophys Res Commun 216:947-956.
9. Barwick JL, Quattrochi LC, Mills AS, Potenza C, Tukey RH, and Guzelian PS (1996) Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol Pharmacol 50:10-16.
10. Beato M, Herrlich P, and Schütz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
11. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, and Feingold KR (2000) The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275:16390-16399.
12. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, and Feingold KR (2002) Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Biophys Res Commun 293:145-149.
13. Bertilsson G, Berkenstam A, and Blomquist P (2001) Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7. Biochem Biophys Res Commun 280:139-144.
14. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Baeckman M, Ohlsson R, Postlind H, Blomquist P, and Berkenstam A (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95:12208-12213.
15. Blizard D, Sueyoshi T, Negishi M, Dehal SS, and Kupfer D (2001) Mechanism of induction of cytochrome p450 enzymes by the proestrogenic endocrine disruptor pesticide-methoxychlor: interactions of methoxychlor metabolites with the constitutive androstane receptor system. Drug Metab Dispos 29:781-785.
16. Blumberg B and Evans RM (1998) Orphan nuclear receptors-new ligands and new possibilities. Genes Dev 12:3149-3155.
17. Blumberg B, Kang H, Bolado J Jr, Chen H, Craig AG, Moreno TA, Umesono K, Perlmann T, De Robertis EM, and Evans RM (1998a) BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites. Genes Dev 12:1269-1277.
18. Blumberg B, Sabbagh W Jr, Juguilon H, Bolado J Jr, van Meter CM, Ong ES, and Evans RM (1998b) SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12:3195-3205.
19. Bohan A and Boyer JL (2002) Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin Liver Dis 22:123 -136.
20. Brigelius-Flohe R (2003) Vitamin E and drug metabolism. Biochem Biophys Res Commun 305:737 -740.
21. Bulera S, Eddy SM, Ferguson E, Jatkoe TA, Reindel JF, Bleavins MR, and de la Iglesia F (2001) RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33:1239-1258.
22. Burger H-J, Schuetz EG, Schuetz JD, and Guzelian PS (1990) Divergent effects of cycloheximide on the induction of class II and class III cytochrome P450 mRNAs in cultures of adult rat hepatocytes. Arch Biochem Biophys 281:204-211.
23. Burk O, Tegude H, Koch I, Hustert E, Wolbold R, Glaeser H, Klein K, Fromm MF, Nuessler AK, Neuhaus P, et al. (2002) Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. J Biol Chem 277:24280-24288.
24. Cai Y, Konishi T, Han G, Campwala KH, French SW, and Wan YJ (2002) The role of hepatocyte RXRalpha in xenobiotic-sensing nuclear receptor-mediated pathways. Eur J Pharm Sci 15:89 -96.
25. Chang TK, Bandiera SM, and Chen J (2003) Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab Dispos 31:7-10.
26. Chawla A, Repa JJ, Evans RM, and Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: opening the X-files. Science (Wash DC) 294:1866-1870.
27. Cheng PY and Morgan ET (2001) Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab 2:165-183.
28. Cherrington NJ, Hartley DP, Li N, Johnson DR, and Klaassen CD (2002) Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2 and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300:97-104.
29. Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, and Moore DD (1997) Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem 272:23565-23571.
30. Choi HS, Seol W, and Moore DD (1996) A component of the 26S proteasome binds on orphan member of the nuclear hormone receptor superfamily. J Steroid Biochem Mol Biol 56:23-30.
31. Conney AH, Davison C, Gastel R, and Burns JJ (1960) Adaptive increase in drug-metabolizing enzymes induced by phenobarbital and other drugs. J Pharmacol Exp Ther 130:1-8.
32. Corcos L and Lagadic-Gossmann D (2001) Gene induction by phenobarbital: an update on an old question that receives key novel answers. Pharmacol Toxicol 89:113-122.
33. Coumoul X, Diry M, and Barouki R (2002) PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochem Pharmacol 64:1513-1519.
34. Daborn PJ, Yen JL, Bogwitz MR, Le Goff G, Feil E, Jeffers S, Tijet N, Perry T, Heckel D, Batterham P, et al. (2002) A single p450 allele associated with insecticide resistance in Drosophila. Science (Wash DC) 297:2253-2256.
35. Davidson BP, Dogra SC, and May BK (2001) A duplicated HNF-3 binding site in the CYP2H2 promoter underlies the weak phenobarbital induction response. Int J Biochem Cell Biol 33:1080-1093.
36. Denison MS and Whitlock JP Jr (1995) Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem 270:18175-18178.
37. Dogra SC, Davidson BP, and May BK (1999) Analysis of a phenobarbital-responsive enhancer sequence located in the 5′ flanking region of the chicken CYP2H1 gene: identification and characterization of functional protein-binding sites. Mol Pharmacol 55:14-22.
38. Dogra SC, Hahn CN, and May BK (1993) Superinduction by cycloheximide of cytochrome P4502H1 and 5-aminolevulinate synthase gene transcription in chick embryo liver. Arch Biochem Biophys 300:531-534.
39. Dogra SC and May BK (1996) Phenobarbital-induced activation of CYP2H1 and 5-aminolevulinate synthase genes in chick embryo hepatocytes is blocked by an inhibitor of protein phosphorylation. Arch Biochem Biophys 327:271-278.
40. Dogra SC and May BK (1997) Liver-enriched transcription factors, HNF-1, HNF-3 and C/EBP, are major contributors to the strong activity of the chicken CYP2H1 promoter in chick embryo hepatocytes. DNA Cell Biol 16:1407-1418.
41. Dogra SC, Tremethick D, and May BK (2003) Evidence that the coactivator CBP/p300 is important for phenobarbital-induced but not basal expression of the CYP2H1 gene. Mol Pharmacol 63:73-80.
42. Dogra SC, Whitelaw ML, and May BK (1998) Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clin Exp Pharmacol Physiol 25:1-9.
43. Dotzlaw H, Leygue E, Watson P, and Murphy LC (1999) The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res 5:2103-2107.
44. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, and Vilarem MJ (2002) Expression of CYP3A4, CYP2B6 and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277:25125-25132.
45. Drocourt L, Pascussi JM, Assenat E, Fabre JM, Maurel P, and Vilarem MJ (2001) Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B and CYP2C in human hepatocytes. Drug Metab Dispos 29:1325-1331.
46. Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA, and Runge-Morris M (2002) Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 30:997-1004.
47. Dunkov BC, Guzov VM, Mocelin G, Shotkoski F, Brun A, Amichot M, Ffrench-Constant RH, and Feyereisen R (1997) The Drosophila cytochrome P450 gene Cyp6a2: structure, localization, heterologous expression and induction by phenobarbital. DNA Cell Biol 16:1345-1356.
48. Dussault I, Lin M, Hollister K, Fan M, Termini J, Sherman MA, and Forman BM (2002) A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol Cell Biol 22:5270-5280.
49. Dussault I, Lin M, Hollister K, Wang EH, Synold TW, and Forman BM (2001) Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor sxr. J Biol Chem 276:33309 -33312.
50. Dussault I, Yoo HD, Lin M, Wang E, Fan M, Batta AK, Salen G, Erickson SK, and Forman BM (2003) Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc Natl Acad Sci USA 100:833-838.
51. Ekins S and Erickson JA (2002) A pharmacophore for human pregnane X receptor ligands. Drug Metab Dispos 30:96-99.
52. Ekins S, Mirny L, and Schuetz EG (2002) A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha and LXRbeta. Pharm Res (NY) 19:1788-1800.
53. Ekins S and Schuetz E (2002) The PXR crystal structure: the end of the beginning. Trends Pharmacol Sci 23:49-50.
54. Enmark E and Gustafsson JA (1996) Orphan nuclear receptors-the first eight years. Mol Endocrinol 10:1293-1307.
55. Enmark E and Gustafsson JA (2001) Comparing nuclear receptors in worms, flies and humans. Trends Pharmacol Sci 22:611-615.
56. Falkner KC, Pinaire JA, Xiao GH, Geoghegan TE, and Prough RA (2001) Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol 60:611-619.
57. Ferguson SS, Chen Y, Negishi M, and Goldstein JA (2002a) Identification of a constitutive androstane receptor (CAR) binding site in the promoter region of CYP2C19. Drug Metab Rev 34 (Suppl 1):111.
58. Ferguson SS, LeCluyse EL, Negishi M, and Goldstein JA (2002b) Induction of CYP2C8 by rifampicin is mediated via a novel pregnane X receptor (PXR) binding site in the CYP2C8 promoter. Drug Metab Rev 34 (Suppl 1):111.
59. Ferguson SS, LeCluyse EL, Negishi M, and Goldstein JA (2002c) Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol 62:737-746.
60. Feyereisen R (1999) Insect P450 enzymes. Annu Rev Entomol 44:507-533.
61. Fonné-Pfister R and Meyer UA (1987) Mechanisms of phenobarbital-type induction of cytochrome P-450 isozymes. Pharmacol Ther 33:19-22.
62. Forman BM (2001) Polymorphisms in promiscuous PXR: an explanation for interindividual differences in drug clearance? Pharmacogenetics 11:551-552.
63. Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, and Moore DD (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature (Lond) 395:612-615.
64. Fraser DJ, Podvinec M, Kaufmann MR, and Meyer UA (2002) Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR). J Biol Chem 277:34717-34726.
65. Frueh FW, Zanger UM, and Meyer UA (1997) Extent and character of phenobarbital-mediated changes in gene expression in liver. Mol Pharmacol 51:363-369.
66. Fukuen S, Fukuda T, Matsuda H, Sumida A, Yamamoto I, Inaba T, and Azuma J (2002) Identification of the novel splicing variants for the hPXR in human livers. Biochem Biophys Res Commun 298:433-438.
67. Fulco AJ (1991) P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. Annu Rev Pharmacol Toxicol 31:177-203.
68. Galisteo M, Marc N, Fautrel A, Guillouzo A, Corcos L, and Lagadic-Gossmann D (1999) Involvement of cyclic nucleotide- and calcium-regulated pathways in phenobarbital-induced cytochrome P-450 3A expression in mouse primary hepatocytes. J Pharmacol Exp Ther 290:1270-1277.
69. Ganem LG, Trottier E, Anderson A, and Jefcoate CR (1999) Phenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple Inducers. Toxicol Appl Pharmacol 155:32-42.
70. Garcia-Allan C, Lord PG, Loughlin JM, Orton TC, and Sidaway JE (2000) Identification of phenobarbitone-modulated genes in mouse liver by differential display. J Biochem Mol Toxicol 14:65-72.
71. Geick A, Eichelbaum M, and Burk O (2001) Nuclear receptor response elements mediate induction of intestinal mdr1 by rifampin. J Biol Chem 276:14581-14587.
72. Gerbal-Chaloin S, Daujat M, Pascussi JM, Pichard-Garcia L, Vilarem MJ, and Maurel P (2002) Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277:209 -217.
73. Gerhold D, Lu M, Xu J, Austin C, Caskey CT, and Rushmore T (2001) Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol Genomics 5:161-170.
74. Gillam E (2002) 'S-SXR-RMs'? Selective SXR response modulators-the future of designer drug interactions? Trends Pharmacol Sci 23:355.
75. Gillam EM (2001) The PXR ligand-binding domain: how to be picky and promiscuous at the same time. Trends Pharmacol Sci 22:448.
76. Gonzalez FJ and Kasper CB (1982) Cloning of DNA complementary to rat liver NADPH-cytochrome c (P-450) oxidoreductase and cytochrome P-450b mRNAs: evidence that phenobarbital augments transcription of specific genes. J Biol Chem 257:5962-5968.
77. Gonzalez FJ, Ueno T, Umeno M, Song BJ, Veech RL, and Gelboin HV (1991) Microsomal ethanol oxidizing system: transcriptional and posttranscriptional regulation of cytochrome P450, CYP2E1. Alcohol Alcohol Suppl 1:97-101.
78. Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, Leitersdorf E, Mangelsdorf DJ, Kliewer SA, and Repa JJ (2003) Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA 100:223-228.
79. Goodwin B, Hodgson E, D'Costa DJ, Robertson GR, and Liddle C (2002a) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 62:359-365.
80. Goodwin B, Hodgson E, and Liddle C (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329-1339.
81. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1 and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526.
82. Goodwin B and Kliewer SA (2002) Nuclear receptors. I. Nuclear receptors and bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol 282:G926-G931.
83. Goodwin B, Moore LB, Stoltz CM, McKee DD, and Kliewer SA (2001) Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60:427-431.
84. Goodwin B, Redinbo MR, and Kliewer SA (2002b) Regulation of cyp3a gene transcription by the pregnane X receptor. Annu Rev Pharmacol Toxicol 42:1-23.
85. Grün F, Venkatesan RN, Tabb MM, Zhou C, Cao J, Hemmati D, and Blumberg B (2002) Benzoate X receptor alpha and beta are pharmacologically distinct and do not function as xenobiotic receptors. J Biol Chem 277:43691-43697.
86. Guo GL, Staudinger J, Ogura K, and Klaassen CD (2002) Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor. Mol Pharmacol 61:832-839.
87. Hahn CN, Hansen AJ, and May BK (1991) Transcriptional regulation of the chicken CYP2H1 gene. J Biol Chem 266:17031-17039.
88. Handschin C and Meyer UA (2000) A conserved nuclear receptor consensus sequence (DR-4) mediates transcriptional activation of the chicken CYP2H1 gene by phenobarbital in a hepatoma cell line. J Biol Chem 275:13362-13369.
89. Handschin C, Podvinec M, Amherd R, Looser R, Ourlin JC, and Meyer UA (2002) Cholesterol and bile acids regulate xenosensor signaling in drug-mediated induction of cytochromes P450. J Biol Chem 277:29561-29567.
90. Handschin C, Podvinec M, Looser R, Amherd R, and Meyer UA (2001a) Multiple enhancer units mediate drug induction of cyp2h1 by xenobiotic-sensing orphan nuclear receptor chicken xenobiotic receptor. Mol Pharmacol 60:681-689.
91. Handschin C, Podvinec M, and Meyer UA (2000) CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proc Natl Acad Sci USA 97:10769-10774.
92. Handschin C, Podvinec M, Stöckli J, Hoffmann K, and Meyer UA (2001b) Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor and pregnane X receptor, from birds to humans. Mol Endocrinol 15:1571-1585.
93. Hankinson O (1995) The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340.
94. He JS and Fulco AJ (1991) A barbiturate-regulated protein binding to a common sequence in the cytochrome P450 genes of rodents and bacteria. J Biol Chem 266:7864-7869.
95. Heath LA, Jones EA, and Old RW (2000) Expression pattern of BXR suggests a role for benzoate ligand-mediated signalling in hatching gland function. Int J Dev Biol 44(1 Spec No):141-144.
96. Hermanson O, Glass CK, and Rosenfeld MG (2002) Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13:55-60.
97. Hirsch-Ernst KI, Schlaefer K, Bauer D, Heder AF, and Kahl GF (2001) Repression of phenobarbital-dependent CYP2B1 mRNA induction by reactive oxygen species in primary rat hepatocyte cultures. Mol Pharmacol 59:1402-1409.
98. Honkakoski P, Moore R, Gynther J, and Negishi M (1996) Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes. J Biol Chem 271:9746-9753.
99. Honkakoski P, Moore R, Washburn KA, and Negishi M (1998a) Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene. Mol Pharmacol 53:597-601.
100. Honkakoski P and Negishi M (1997) Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J Biol Chem 272:14943-14949.
101. Honkakoski P and Negishi M (1998a) Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem J 330:889 -895.
102. Honkakoski P and Negishi M (1998b) Regulatory DNA elements of phenobarbital-responsive cytochrome P450 CYP2B genes. J Biochem Mol Toxicol 12:3-9.
103. Honkakoski P and Negishi M (2000) Regulation of cytochrome P450 (P450) genes by nuclear receptors. Biochem J 347:321-337.
104. Honkakoski P, Sueyoshi T, and Negishi M (2003) Drug-activated nuclear receptors CAR and PXR. Ann Med 35:172-182.
105. Honkakoski P, Zelko I, Sueyoshi T, and Negishi M (1998b) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18:5652-5658.
106. Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, and Moore DD (2003) Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci USA 100:4156 -4161.
107. Huss JM and Kasper CB (1998) Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. J Biol Chem 273:16155-16162.
108. Huss JM, Wang SI, Astrom A, McQuiddy P, and Kasper CB (1996) Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif. Proc Natl Acad Sci USA 93:4666-4670.
109. Hustert E, Zibat A, Presecan-Siedel E, Eiselt R, Mueller R, Fuss C, Brehm I, Brinkmann U, Eichelbaum M, Wojnowski L, and Burk O (2001) Natural protein variants of pregnane X receptor with altered transactivation activity toward cyp3a4. Drug Metab Dispos 29:1454-1459.
110. Iwahori T, Matsuura T, Maehashi H, Sugo K, Saito M, Hosokawa M, Chiba K, Masaki T, Aizaki H, Ohkawa K, and Suzuki T (2003) CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology 37:665-673.
111. Jacobs MN, Dickins M, and Lewis DF (2003) Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure. J Steroid Biochem Mol Biol 84:117-132.
112. Jakoby WB (1994) Detoxication: Conjugation and hydrolysis, in The Liver: Biology and Pathobiology (Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, and Shafritz DA eds.) pp 429-442, Raven Press, New York, NY.
113. Johnson EF, Palmer CN, Griffin KJ, and Hsu MH (1996) Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J 10:1241-1248.
114. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NC, LeCluyse EL, Lambert MH, Willson TM, et al. (2000) The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14:27-39.
115. Jover R, Bort R, Gomez-Lechon MJ, and Castell JV (2002) Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J 16:1799-1801.
116. Kakizaki S, Karami S, and Negishi M (2002) Retinoic acids repress constitutive active receptor-mediated induction by 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene of the CYP2B10 gene in mouse primary hepatocytes. Drug Metab Dispos 30:208-211.
117. Kakizaki S, Yamamoto Y, Ueda A, Moore R, Sueyoshi T, and Negishi M (2003) Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR. Biochim Biophys Acta 1619:239-242.
118. Kamiya A, Inoue Y, and Gonzalez FJ (2003) Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 37:1375-1384.
119. Karpen SJ (2002) Nuclear receptor regulation of hepatic function. J Hepatol 36:832-850.
120. Kassam A, Winrow CJ, Fernandez-Rachubinski F, Capone JP and Rachubinski RA (2000) The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated transactivation. J Biol Chem 275:4345-4350.
121. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, and Edwards PA (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor and constitutive androstane receptor. J Biol Chem 277:2908-2915.
122. Kawamoto T, Kakizaki S, Yoshinari K, and Negishi M (2000) Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 14:1897-1905.
123. Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, and Negishi M (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19:6318-6322.
124. Kawamura A, Yoshida Y, Kimura N, Oda H, and Kakinuma A (1999) Phosphorylation/dephosphorylation steps are crucial for the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital. Biochem Biophys Res Commun 264:530-536.
125. Kemper B (1998) Regulation of cytochrome P450 gene transcription by phenobarbital. Prog Nucleic Acid Res Mol Biol 61:23-64.
126. Kerr TA, Saeki S, Schneider M, Schaefer K, Berdy S, Redder T, Shan B, Russell DW, and Schwarz M (2002) Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2:713-720.
127. Kim J and Kemper B (1997) Phenobarbital alters protein binding to the CYP2B1/2 phenobarbital-responsive unit in native chromatin. J Biol Chem 272:29423-29425.
128. Kim J, Min G, and Kemper B (2001) Chromatin assembly enhances binding to the CYP2B1 PBRU of NF-1, which binds simultaneously with CAR/RXR and enhances CAR/RXR-mediated activation of the PBRU. J Biol Chem 276:7559-7567.
129. Kim J, Rivera-Rivera I, and Kemper B (2000) Tissue-specific chromatin structure of the phenobarbital-responsive unit and proximal promotor of CYP2B1/ 2 and modulation by phenobarbital. Nucleic Acids Res 28:1126 -1132.
130. Kliewer SA, Goodwin B, and Willson TM (2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23:687-702.
131. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, et al. (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73-82.
132. Kliewer SA and Willson TM (2002) Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 43:359-364.
133. Kocarek TA, Kraniak JM, and Reddy AB (1998) Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver. Mol Pharmacol 54:474-484.
134. Kocarek TA and Mercer-Haines NA (2002) Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. Mol Pharmacol 62:1177-1186.
135. Kocarek TA, Shenoy SD, Mercer-Haines NA, and Runge-Morris M (2002) Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes. J Pharmacol Toxicol Methods 47:177-187.
136. Lamba JK, Lin YS, Schuetz EG, and Thummel KE (2002) Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 54:1271-1294.
137. Landes N, Pfluger P, Kluth D, Birringer M, Ruhl R, Bol GF, Glatt H, and Brigelius-Flohe R (2003) Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 65:269-273.
138. Ledda-Columbano GM, Pibiri M, Concas D, Molotzu F, Simbula G, Cossu C, and Columbano A (2003) Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP. Carcinogenesis 24:1059-1065.
139. Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, and Moore DD (2000) The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol 20:187-195.
140. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, and Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interaction. J Clin Investig 102:1016-1023.
141. Li J, Ning G, and Duncan SA (2000) Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14:464-474.
142. Li W, Petersen RA, Schuler MA, and Berenbaum MR (2002) CYP6B cytochrome P450 monooxygenases from Papilio canadensis and Papilio glaucus: potential contributions of sequence divergence to host plant associations. Insect Mol Biol 11:543-551.
143. Liang Q, He JS, and Fulco AJ (1995) The role of Barbie box sequences as cis-acting elements involved in the barbiturate-mediated induction of cytochromes P450BM-1 and P450BM-3 in Bacillus megaterium. J Biol Chem 270:4438-4450.
144. Liddle C and Goodwin B (2002) Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR. Semin Liver Dis 22:115-122.
145. Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517-544.
146. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (Lond) 418:797-801.
147. Lindblom TH, Pierce GJ, and Sluder AE (2001) A C. elegans orphan nuclear receptor contributes to xenobiotic resistance. Curr Biol 11:864-868.
148. Liu S, Park Y, Rivera-Rivera I, Li H, and Kemper B (1998) Nuclear factor-1 motif and redundant regulatory elements comprise phenobarbital-responsive enhancer in CYP2B1/2. DNA Cell Biol 17:461-470.
149. Liu S, Rivera-Rivera I, Bredemeyer AJ, and Kemper B (2001) Functional analysis of the phenobarbital-responsive unit in rat CYP2B2. Biochem Pharmacol 62:21-28.
150. Lowell BB and Spiegelman BM (2000) Towards a molecular understanding of adaptive thermogenesis. Nature (Lond) 404:652-660.
151. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, and Mangelsdorf DJ (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515.
152. Ma Q (2001) Induction of CYA1A1. The AhR/DRE paradigm: transcription, receptor regulation and expanding biological roles. Curr Drug Metab 2:149 -164.
153. Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, and Moore JT (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278:17277-17283.
154. Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, and Kliewer SA (2002) Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62:638-646.
155. Makinen J, Frank C, Jyrkkarinne J, Gynther J, Carlberg C, and Honkakoski P (2002) Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol 62:366-378.
156. Mangelsdorf DJ and Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841-850.
157. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, and Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83:835-839.
158. Marc N, Galisteo M, Lagadic-Gossmann D, Fautrel A, Joannard F, Guillouzo A, and Corcos L (2000) Regulation of phenobarbital induction of the cytochrome P450 2b9/10 genes in primary mouse hepatocyte culture. Involvement of calcium- and cAMP-dependent pathways. Eur J Biochem 267:963-970.
159. Masuyama H, Hiramatsu Y, Kunitomi M, Kudo T, and MacDonald PN (2000) Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate pregnane X receptor-mediated transcription. Mol Endocrinol 14:421-428.
160. Matsuda H, Kinoshita K, Sumida A, Takahashi K, Fukuen S, Fukuda T, Yamamoto I, and Azuma J (2002) Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line. Biochim Biophys Acta 1593:93-98.
161. Meyer UA (1996) Overview of enzymes of drug metabolism. J Pharmacokinet Biopharm 25:449 -459.
162. Meyer UA (2000) Pharmacogenetics and adverse drug reactions. Lancet 356:1667-1671.
163. Meyer UA and Hoffmann K (1999) Phenobarbital-mediated changes in gene expression in the liver. Drug Metab Rev 31:365-373.
164. Meyer UA and Zanger UM (1997) Molecular mechanism of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 37:269-296.
165. Min G, Kemper JK, and Kemper B (2002a) Glucocorticoid receptor-interacting protein 1 mediates ligand-independent nuclear translocation and activation of constitutive androstane receptor in vivo. J Biol Chem 277:26356 -26363.
166. Min G, Kim H, Bae Y, Petz L, and Kemper JK (2002b) Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J Biol Chem 277:34626 -34633.
167. Miyata M, Nagata K, Yamazoe Y, and Kato R (1995) Transcriptional elements directing a liver-specific expression of P450/6 beta A (CYP3A2) gene-encoding testosterone 6 beta-hydroxylase. Arch Biochem Biophys 318:71-79.
168. Moore JT, Moore LB, Maglich JM, and Kliewer SA (2003) Functional and structural comparison of PXR and CAR. Biochim Biophys Acta 1619:235-238.
169. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, and Kliewer SA (2000a) St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500 -7502.
170. Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, Lambert MH, and Moore JT (2002) Pregnane X receptor (PXR), constitutive androstane receptor (CAR) and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol Endocrinol 16:977-986.
171. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, et al. (2000b) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122-15127.
172. Morgan ET, Sewer MB, Iber H, Gonzalez FJ, Lee Y-H, Tukey RH, Okino S, Vu T, Chen Y-H, Sidhu JS, and Omiecinski CJ (1996) Physiological and pathophysiological regulation of cytochrome P450. Drug Metab Dispos 26:1232-1240.
173. Morgan ET, Ullrich V, Daiber A, Schmidt P, Takaya N, Shoun H, McGiff JC, Oyekan A, Hanke CJ, Campbell WB, et al. (2001) Cytochromes P450 and flavin monooxygenases-targets and sources of nitric oxide. Drug Metab Dispos 29:1366-1376,
174. Muangmoonchai R, Smirlis D, Wong SC, Edwards M, Phillips IR, and Shephard EA (2001) Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1. Biochem J 355:71-78.
175. Muller M (2000) Transcriptional control of hepatocanalicular transporter gene expression. Semin Liver Dis 20:323-337.
176. Nebert DW and Gonzalez FJ (1987) P450 genes: structure, evolution, and regulation, Annu Rev Biochem 56:945-993.
177. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162.
178. Negishi M and Honkakoski P (2000) Induction of drug metabolism by nuclear receptor CAR: molecular mechanisms and implications for drug research. Eur J Pharm Sci 11:259 -264.
179. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
180. Nirodi CS, Sultana S, Ram N, Prabhu L, and Padmanaban G (1996) Involvement of synthesis and phosphorylation of nuclear protein factors that bind to the positive cis-acting element in the transcriptional activation of the CYP2B1/B2 gene by phenobarbitone in vivo. Arch Biochem Biophys 331:79-86.
181. Nishikawa J, Saito K, Sasaki M, Tomigahara Y, and Nishihara T (2000) Molecular cloning and functional characterization of a novel nuclear receptor similar to an embryonic benzoate receptor BXR. Biochem Biophys Res Commun 277:209-215.
182. Nuclear Receptors Nomenclature Committee (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-163.
183. Okey AB (1990) Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45:241-298.
184. Ostberg T, Bertilsson G, Jendeberg L, Berkenstam A, and Uppenberg J (2002) Identification of residues in the PXR ligand binding domain critical for species specific and constitutive activation. Eur J Biochem 269:4896-4904.
185. Ourlin JC, Handschin C, Kaufmann M, and Meyer UA (2002) A link between cholesterol levels and phenobarbital induction of cytochromes P450. Biochem Biophys Res Commun 291:378-384.
186. Ourlin JC, Lasserre F, Pineau T, Fabre JM, Sa-Cunha A, Maurel P, Vilarem MJ, and Pascussi JM (2003) The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity. Mol Endocrinol 17:1693-1703.
187. Owsley E and Chiang JY (2003) Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene. Biochem Biophys Res Commun 304:191-195.
188. Paquet Y, Trottier E, Beaudet MJ, and Anderson A (2000) Mutational analysis of the CYP2B2 phenobarbital response unit and inhibitory effect of the constitutive androstane receptor on phenobarbital responsiveness. J Biol Chem 275:38427-38436.
189. Park Y, Li H, and Kemper B (1996) Phenobarbital induction mediated by a distal CYP2B2 sequence in rat liver transiently transfected in situ. J Biol Chem 271:23725-23728.
190. Pascussi JM, Busson-Le Coniat M, Maurel P, and Vilarem MJ (2003a) Transcriptional analysis of the orphan nuclear receptor CAR (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol Endocrinol 17:42-55.
191. Pascussi JM, Drocourt L, Fabre JM, Maurel P, and Vilarem MJ (2000a) Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 58:361-372.
192. Pascussi JM, Drocourt L, Gerbal-Chaloin S, Fabre JM, Maurel P, and Vilarem MJ (2001) Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 268:6346-6358.
193. Pascussi JM, Gerbal-Chaloin S, Drocourt L, Maurel P, and Vilarem MJ (2003b) The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619:243-253.
194. Pascussi JM, Gerbal-Chaloin S, Fabre JM, Maurel P, and Vilarem MJ (2000b) Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 58:1441-1450.
195. Pascussi JM, Gerbal-Chaloin S, Pichard-Garcia L, Daujat M, Fabre JM, Maurel P, and Vilarem MJ (2000c) Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 274:707-713.
196. Pascussi JM, Jounaidi Y, Drocourt L, Domergue J, Balabaud C, Maurel P, and Vilarem MJ (1999) Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem Biophys Res Commun 260:377-381.
197. Petersen RA, Niamsup H, Berenbaum MR, and Schuler MA (2003) Transcriptional response elements in the promotor of CYP6B1, an insect P450 regulated by plant chemicals. Biochim Biophys Acta 1619:269 -282.
198. Podvinec M, Kaufmann MR, Handschin C, and Meyer UA (2002) NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol 16:1269-1279.
199. Prabhu L, Upadhya P, Ram N, Nirodi CS, Sultana S, Vatsala PG, Mani SA, Rangarajan PN, Surolia A, and Padmanaban G (1995) A model for the transcriptional regulation of the CYP2B1/B2 gene in rat liver. Proc Natl Acad Sci USA 92:9628-9632.
200. Puigserver P and Spiegelman BM (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24:76 -90.
201. Quattrochi LC and Guzelian PS (2001) Cyp3a regulation: from pharmacology to nuclear receptors. Drug Metab Dispos 29:615-622.
202. Quattrochi LC, Mills AS, Barwick JL, Yockey CB, and Guzelian PS (1995) A novel cis-acting element in a liver cytochrome P450 3A gene confers synergistic induction by glucocorticoids plus antiglucocorticoids. J Biol Chem 270:28917-28923.
203. Ramsden R, Beck NB, Sommer KM, and Omiecinski CJ (1999) Phenobarbital responsiveness conferred by the 5′-flanking region of the rat CYP2B2 gene in transgenic mice. Gene 228:169-179.
204. Ramsden R, Sommer KM, and Omiecinski CJ (1993) Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J Biol Chem 268:21722-21726.
205. Ranson H, Claudianos C, Ortelli F, Abgrall C, Hemingway J, Sharakhova MV, Unger MF, Collins FH, and Feyereisen R (2002) Evolution of supergene families associated with insecticide resistance. Science (Wash DC) 298:179-181.
206. Raucy JL (2003) Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 31:533-539.
207. Remmer H (1958) Die Beschleunigung des Abbaues als Ursache der Gewöhnung an Barbiturate. Naturwissenschaften 46:580-581.
208. Remmer H (1972) Induction of drug metabolizing enzyme system in the liver. Eur J Clin Pharmacol 5:116-136.
209. Remmer H and Merker HJ (1963) Enzyme induction and increase of endoplasmic reticulum in liver cells during phenobarbital (Luminal) treatment. Klin Wochenschr 41:276-282.
210. Repa JJ and Mangelsdorf DJ (2000) The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 16:459-481.
211. Ripp SL, Fitzpatrick JL, Peters JM, and Prough RA (2002) Induction of CYP3A expression by dehydroepiandrosterone; involvement of the pregnane X receptor. Drug Metab Dispos 30:570-575.
212. Rivera-Rivera I, Kim J, and Kemper B (2003) Transcriptional analysis in vivo of the hepatic genes, Cyp2b9 and Cyp2b10, by intravenous administration of plasmid DNA in mice. Biochim Biophys Acta 1619:254-262.
213. Rodriguez AD (2002) Drug-Drug Interactions, Marcel Dekker, Inc., New York, NY.
214. Rosenfeld JM, Vargas R Jr, Xie W, and Evans RM (2003) Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor PXR. Mol Endocrinol 17:1268-1282.
215. Rosenfeld MG and Glass CK (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276:36865-36868.
216. Roy-Chowdhury J, Locker J, and Roy-Chowdhury N (2003) Nuclear receptors orchestrate detoxification pathways. Dev Cell 4:607-608.
217. Sakuma T, Ohtake M, Katsurayama Y, Jarukamjorn K, and Nemoto N (1999) Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbon-responsive and -nonresponsive mice. Drug Metab Dispos 27:379-384.
218. Salonpaa P, Pelkonen O, Kojo A, Pasanen M, Negishi M, and Raunio H (1994) Cytochrome P4502A5 expression and inducibility by phenobarbital is modulated by cAMP in mouse primary hepatocytes. Biochem Biophys Res Commun 205:631-637.
219. Samudre KR, Mani SA, Vathsala PG, Rangarajan PN, and Padmanaban G (2002) Phenobarbitone-mediated translocation of the cytosolic proteins interacting with the 5′-proximal region of rat liver CYP2B1/B2 gene into the nucleus. Biochem Biophys Res Commun 292:312-317.
220. Savas U, Griffin KJ, and Johnson EF (1999) Molecular mechanisms of cytochrome P-450 induction by xenobiotics: An expanded role for nuclear hormone receptors. Mol Pharmacol 56:851-857.
221. Savas U, Wester MR, Griffin KJ, and Johnson EF (2000) Rabbit pregnane X receptor is activated by rifampicin. Drug Metab Dispos 28:529-537.
222. Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, and Watkins PB (2001) Induction of cyp3a4 by 1alpha, 25-dihydroxyvitamin d(3) is human cell line-specific and is unlikely to involve pregnane x receptor. Drug Metab Dispos 29:1446-1453.
223. Schuetz EG, Brimer C, and Schuetz JD (1998) Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response Element. Mol Pharmacol 54:1113-1117.
224. Schuetz EG, Schmid W, Schütz G, Brimer C, Yasuda K, Kamataki T, Bornheim L, Myles K, and Cole TJ (2000) The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver. Drug Metab Dispos 28:268-278.
225. Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, et al. (2001) Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters and cytochrome P450. J Biol Chem 276:39411-39418.
226. Seol W, Choi HS, and Moore DD (1996) An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimeizes with other receptors. Science (Wash DC) 272:1336-1339.
227. Shaw GC and Fulco AJ (1993) Inhibition by barbiturates of the binding of Bm3R1 repressor to its operator site on the barbiturate-inducible cytochrome P450BM-3 gene of Bacillus megaterium. J Biol Chem 268:2997-3004.
228. Shaw GC, Hsueh YH, and Kao HS (2000) The basal-level expression of the cytochrome P450(BM-1) gene is negatively affected by the bm1P1 gene of Bacillus megaterium. Curr Microbiol 40:47-50.
229. Shaw GC, Sung CC, Liu CH, and Lin CH (1998) Evidence against the Bm1P1 protein as a positive transcription factor for barbiturate-mediated induction of cytochrome P450BM-1 in Bacillus megaterium, J Biol Chem 273:7996-8002.
230. Shi Y, Downes M, Xie W, Kao HY, Ordentlich P, Tsai CC, Hon M, and Evans RM (2001) Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev 15:1140-1151.
231. Shiraki T, Sakai N, Kanaya E, and Jingami H (2003) Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. J Biol Chem 278:11344 -11350.
232. Sidhu JS and Omiecinski CJ (1995) cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures. J Biol Chem 270:12762-12773.
233. Sidhu JS and Omiecinski CJ (1996) Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP. J Pharmacol Exp Ther 276:238-245.
234. Sidhu JS and Omiecinski CJ (1997) An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J Pharmacol Exp Ther 282:1122-1129.
235. Sidhu JS and Omiecinski CJ (1998) Protein synthesis inhibitors exhibit a nonspecific effect on phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocytes. J Biol Chem 273:4769 -4775.
236. Simpson AE (1997) The cytochrome P450 4 (CYP4) family. Gen Pharmacol 28:351-359.
237. Smirlis D, Muangmoonchai R, Edwards M, Phillips IR, and Shephard EA (2001) Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics. J Biol Chem 276:12822-12826.
238. Sonoda J, Rosenfeld JM, Xu L, Evans RM, and Xie W (2003) A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Curr Drug Metab 4:59-72.
239. Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, and Evans RM (2002) Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 99:13801-13806.
240. Staudinger J, Liu Y, Madan A, Habeebu S, and Klaassen CD (2001a) Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane x receptor. Drug Metab Dispos 29:1467-1472.
241. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, et al. (2001b) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98:3369-3374.
242. Staudinger JL, Madan A, Carol KM, and Parkinson A (2003) Regulation of drug transporter gene expression by nuclear receptors. Drug Metab Dispos 31:523-527.
243. Stieger B and Meier PJ (1998) Bile acid and xenobiotic transporters in liver. Curr Opin Cell Biol 10:462-467.
244. Stoltz C and Anderson A (1999) Positive regulation of the rat CYP2B2 phenobarbital response unit by the nuclear receptor hexamer half-site-nuclear factor 1 complex, Biochem Pharmacol 57:1073-1076.
245. Stoltz C, Vachon MH, Trottier E, Dubois S, Paquet Y, and Anderson A (1998) The CYP2B2 phenobarbital response unit contains an accessory factor element and a putative glucocorticoid response element essential for conferring maximal phenobarbital responsiveness. J Biol Chem 273:8528-8536.
246. Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, and Negishi M (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274:6043-6046.
247. Sueyoshi T and Negishi M (2001) Phenobarbital response elements of cytochrome p450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41:123-143.
248. Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH, Owens IS, Negishi M, and Sueyoshi T (2001) The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33:1232-1238.
249. Sultana S, Nirodi CS, Ram N, Prabhu L, and Padmanaban G (1997) A 65-kDa protein mediates the positive role of heme in regulating the transcription of CYP2B1/B2 gene in rat liver. J Biol Chem 272:8895-8900.
250. Suzuki H and Sugiyama Y (2000) Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin Liver Dis 20:251-263.
251. Synold TW, Dussault I, and Forman BM (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584-590.
252. Takeshita A, Taguchi M, Koibuchi N, and Ozawa Y (2002) Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics. J Biol Chem 277:32453-32458.
253. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, and Schuetz E (2001) Transcriptional control of intestinal cytochrome P-4503A by 1alpha, 25-dihydroxy vitamin D(3). Mol Pharmacol 60:1399-1406.
254. Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, et al. (2003) The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9:220-224.
255. Toell A, Kroneke KD, Kleinert H, and Carlberg C (2002) Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands. J Cell Biochem 85:72-82.
256. Trottier E, Belzil A, Stoltz C, and Anderson A (1995) Localization of a phenobarbital-responsive element (PBRE) in the 5′-flanking region of the rat CYP2B2 gene. Gene 158:263-268.
257. Turner R (2002) Muscle regulator goes the distance, Nature (Lond) 418:740.
258. Tzameli I and Moore DD (2001) Role reversal: new insights from new ligands for the xenobiotic receptor CAR, Trends Endocrinol Metab 12:7-10.
259. Tzameli I, Pissios P, Schuetz EG, and Moore DD (2000) The xenobiotic compound 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol 20:2951-2958.
260. Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, and Negishi M (2002a) Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61:1-6.
261. Ueda A, Kakizaki S, Negishi M, and Sueyoshi T (2002b) Residue threonine 350 confers steroid hormone responsiveness to the mouse nuclear orphan receptor CAR. Mol Pharmacol 61:1284-1288.
262. Vidal-Puig A and O'Rahilly S (2001) Metabolism: controlling the glucose factory, Nature (Lond) 413:125-126.
263. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, Flores M, Postic C, Magnuson MA, Chen J, Chien KR, et al. (2000) Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 20:4436-4444.
264. Wang H, Faucette S, Sueyoshi T, Moore R, Ferguson S, Negishi M, and LeCluyse EL (2003a) A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 278:14146 -14152.
265. Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M, and LeCluyse EL (2003b) Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metab Dispos 31:620-630.
266. Wang L, Lee YK, Bundman D, Han Y, Thevananther S, Kim CS, Chua SS, Wei P, Heyman RA, Karin M, and Moore DD (2002) Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2:721-731.
267. Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, and Redinbo MR (2003) 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 42:1430-1438.
268. Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, and Redinbo MR (2001) The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science (Wash DC) 292:2329-2333.
269. Watt AJ, Garrison WD, and Duncan SA (2003) HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37:1249-1253.
270. Waxman DJ (1999) P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR and PPAR. Arch Biochem Biophys 369:11-23.
271. Waxman DJ and Azaroff L (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281:577-592.
272. Waxman DJ, Morrissey JJ, Naik S, and Jauregui HO (1990) Phenobarbital induction of cytochromes P-450: h/gh-level long-term responsivness of primary rat hepatocyte cultures to drug induction and glucocorticoid dependence of the phenobarbital response. Biochem J 271:113-119.
273. Wei P, Zhang J, Dowhan DH, Han Y, and Moore DD (2002) Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J 2:117-126.
274. Wei P, Zhang J, Egan-Hafley M, Liang S, and Moore DD (2000) The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature (Lond) 407:920-923.
275. Wentworth JM, Agostlni M, Love J, Schwabe JW, and Chatterjee VK (2000) St John's wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol 166:R11-R16.
276. Werck-Reichhart D and Feyereisen R (2000) Cytochromes P450: a success story. Genome Biol 1:(6)Reviews.
277. Whitlock JP Jr (1999) Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39:103-125.
278. Willson TM, Jones SA, Moore JT, and Kliewer SA (2001) Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism. Med Res Rev 21:513-522.
279. Xiao L, Cui X, Madison V, White RE, and Cheng KC (2002) Insights from a three-dimensional model into ligand binding to constitutive active receptor. Drug Metab Dispos 30:951-956.
280. Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson MC, Neuschwander-Tetri BA, Brunt EM, Guzelian PS, and Evans RM (2000a) Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature (Lond) 406:435-439.
281. Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, and Evans RM (2000b) Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 14:3014-3023.
282. Xie W and Evans RM (2001) Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem 276:37739-37742.
283. Xie W and Evans RM (2002) Pharmaceutical use of mouse models humanized for the xenobiotic receptor. Drug Discov Today 7:509-515.
284. Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, Waxman DJ, and Evans RM (2001) An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98:3375-3380.
285. Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS, Cabrera GY, Tukey RH, and Evans RM (2003) Control of steroid, heme and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 100:4150-4155.
286. Xiong H, Yoshinari K, Brouwer KL, and Negishi M (2002) Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metab Dispos 30:918-923.
287. Yamamoto Y, Kawamoto T, and Negishi M (2003) The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity. Arch Biochem Biophys 409:207-211.
288. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature (Lond) 413:131-138.
289. Yoshinari K, Sueyoshi T, Moore R, and Negishi M (2001) Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYP2B1 gene by phenobarbital in rat livers. Mol Pharmacol 59:278-284.
290. Zaher H, Yang TJ, Gelboin HV, Fernandez-Salguero P, and Gonzalez FJ (1998) Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse. Biochem Pharmacol 55:235-238.
291. Zelko I and Negishi M (2000) Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes. Biochem Biophys Res Commun 277:1-6.
292. Zelko I, Sueyoshi T, Kawamoto T, Moore R, and Negishi M (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xeno-chemicals in mouse liver. Mol Cell Biol 21:2838-2846.
293. Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W, and Yan B (1999) Rat pregnane X receptor: molecular cloning, tissue distribution and xenobiotic regulation. Arch Biochem Biophys 368:14-22.
294. Zhang J, Huang W, Chua SS, Wei P, and Moore DD (2002) Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science (Wash DC) 298:422-424.
295. Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, et al, (2001) The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11:555-572.
296. Zhou S, Gao Y, Jiang W, Huang M, Xu A, and Paxton JW (2003) Interactions of herbs with cytochrome P450. Drug Metab Rev 35:35-98.
297. Ziegler DM (1994) Detoxicatlon: oxidation and reduction, in The Liver: Biology and Pathobiology (Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, and Shafritz DA eds.), pp 415-427, Raven Press, New York, NY.